+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years +
All Genders
ID05721404

Study of Icodextrin Use to Delay Full Dose Dialysis in Adults Starting Incremental Peritoneal Dialysis

Led by First Affiliated Hospital, Sun Yat-Sen University · Updated on 2026-06-29

194

Participants Needed

1

Research Sites

35 weeks

Total Duration

AI-Summary

What This Trial Is About

This clinical trial studies patients undergoing incremental peritoneal dialysis PD, focusing on whether using icodextrin solution can delay the need to shift from low dose to full dose dialysis within the first year. The study aims to evaluate the effect of icodextrin on fluid removal and clinical outcomes like peritonitis, anuria, hospitalizations, mortality, and quality of life. Patients are randomly assigned to two groups to compare icodextrin with standard glucose-based solutions in managing fluid overload during incremental PD. Participants are randomized 11 to receive either icodextrin Extraneal or hypertonic dextrose solution for their long night dwell when overhydration is detected by bioimpedance analysis ECWTBW 9 or edema. Both groups start with three bags of 2L glucose solution daily, adjusting when overhydration occurs. Patients are monitored every two months for fluid status, clinical symptoms, medication, and dialysis prescriptions. Treatment changes and supportive medications are provided as needed, and patients may switch to full dose dialysis based on clinical signs. Throughout the study, participants undergo regular assessments including fluid status measurement, blood and urine tests, peritoneal function tests, and quality of life surveys. Clinical events such as infections, hospitalizations, dialysis modality changes, and mortality are recorded up to 12 months. The primary outcome is the time to shift from low dose to full dose dialysis. Secondary outcomes include time to first peritonitis, anuria, hospitalization, technical failure, mortality, cardiovascular survival, and quality of life scores. The total duration of participation is about one year with ongoing monitoring.

CONDITIONS

Brief Title

Icodextrin Postpones the Shift of Low Dose to Full Dose Dialysis in the First Year of Incremental Peritoneal Dialysis

Research Team

X

Xiao Yang, Doctor

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here